Edition:
United Kingdom

Cleveland Biolabs Inc (CBLI.OQ)

CBLI.OQ on NASDAQ Stock Exchange Capital Market

1.62USD
14 Nov 2018
Change (% chg)

-- (--)
Prev Close
$1.62
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
3,064
52-wk High
$4.21
52-wk Low
$1.56

Latest Key Developments (Source: Significant Developments)

Cleveland BioLabs reports Q3 ‍net loss per share, excluding minority interests, $0.11
Tuesday, 14 Nov 2017 

Nov 14 (Reuters) - Cleveland BioLabs Inc :Cleveland BioLabs reports third quarter 2017 financial results and development progress.Q3 revenue $300,000 versus $1.1 million.Cleveland BioLabs Inc - qtrly ‍net loss, excluding minority interests, $0.11 per share​.Cleveland BioLabs -current cash,cash equivalents,short-term investments is expected to fund operations for at least 1 year beyond filing date of form 10-Q​.  Full Article